MULTIPLE MYELOMA-AN IN VITRO STUDY
1961

Study of Myeloma Cells in the Lab

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): H. G. Richmond, Y. Ohnuki, A. Awa, C. M. Pomerat

Primary Institution: Pasadena Foundation for Medical Research

Hypothesis

How do myeloma cells behave and respond to chemotherapy in vitro?

Conclusion

Myeloma cells exhibit unique movements and can be affected by the chemotherapy drug NSC-1026, leading to cell death and chromosomal abnormalities.

Supporting Evidence

  • Myeloma cells showed rapid undulation and pulsating extensions.
  • Treatment with NSC-1026 led to cell death within hours at higher concentrations.
  • Chromosomal abnormalities were observed after treatment with NSC-1026.

Takeaway

Scientists looked at myeloma cells in the lab to see how they move and how a new medicine affects them. They found that the medicine can make the cells sick and change their DNA.

Methodology

Myeloma cells were cultured in vitro and observed using phase contrast optics and time-lapse cinematography.

Limitations

Only a small number of cases were studied, and not all samples grew successfully after treatment.

Participant Demographics

Three patients with multiple myeloma, including two females and one male, aged 55, 70, and 63.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication